Big pharma faces an incendiary mix of distrust and austerity

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Big pharma faces an incendiary mix of distrust and austerity

Everyone knows pharmaceutical companies are under pressure as they edge slowly towards (and off) the patent cliff. But now regulators and judges around the world seem to be turning against them too

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login
more from across site and ros bottom lb

More from across our site

Sources at four firms explain how changes to USPTO fees provide opportunities to give clients strategic counselling
Gift this article